首页> 外文期刊>Clinical nephrology >Anti-glomerular basement membrane disease treated with mycophenolate mofetil, corticosteroids, and plasmapheresis
【24h】

Anti-glomerular basement membrane disease treated with mycophenolate mofetil, corticosteroids, and plasmapheresis

机译:霉酚酸酯,皮质类固醇和血浆置换术治疗抗肾小球基底膜疾病

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

An 18-year-old woman presented with anemia, pulmonary hemorrhage, and necrotizing glomerulonephritis, and was diagnosed with anti-glomerular basement membrane (anti-GBM) disease. Treatment was undertaken with plasma exchange, mycophenolate mofetil and corticosteroids, due to patient refusal of cyclophosphamide. Clinical remission was successfully induced with this fertility-sparing regimen. A relapse due to therapy non-adherence was successfully treated with a second course of plas-mapheresis, mycophenolate, and steroids. Thereafter, 6 months of directly observed therapy resulted in a favorable outcome with well-preserved pulmonary and renal function. This case suggests the possibility that mycophenolate may have a role in the treatment of anti-GBM disease.
机译:一名18岁女性出现贫血,肺部出血和坏死性肾小球肾炎,并被诊断出患有抗肾小球基底膜(GBM)疾病。由于患者拒绝使用环磷酰胺,因此进行了血浆置换,霉酚酸酯和皮质类固醇治疗。通过这种保留生育能力的方案成功地诱导了临床缓解。因不坚持治疗而复发的患者已成功接受第二次血浆置换,霉酚酸酯和类固醇治疗。此后,直接观察治疗的6个月结果良好,肺和肾功能得以良好保留。该病例表明霉酚酸酯可能在抗GBM疾病的治疗中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号